Hemagglutination Inhibition Tests
"Hemagglutination Inhibition Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination.
| Descriptor ID |
D006385
|
| MeSH Number(s) |
E01.370.225.812.735.370 E05.200.812.735.370 E05.478.594.760.370
|
| Concept/Terms |
Hemagglutination Inhibition Tests- Hemagglutination Inhibition Tests
- Hemagglutination Inhibition Test
- Inhibition Test, Hemagglutination
- Inhibition Tests, Hemagglutination
- Test, Hemagglutination Inhibition
- Tests, Hemagglutination Inhibition
|
Below are MeSH descriptors whose meaning is more general than "Hemagglutination Inhibition Tests".
Below are MeSH descriptors whose meaning is more specific than "Hemagglutination Inhibition Tests".
This graph shows the total number of publications written about "Hemagglutination Inhibition Tests" by people in this website by year, and whether "Hemagglutination Inhibition Tests" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hemagglutination Inhibition Tests" by people in Profiles.
-
Friel D, Co M, Ollinger T, Salaun B, Schuind A, Li P, Walravens K, Ennis FA, Vaughn DW. Non-neutralizing antibody responses following A(H1N1)pdm09 influenza vaccination with or without AS03 adjuvant system. Influenza Other Respir Viruses. 2021 01; 15(1):110-120.
-
Alera MT, Srikiatkhachorn A, Velasco JM, Tac-An IA, Lago CB, Clapham HE, Fernandez S, Levy JW, Thaisomboonsuk B, Klungthong C, Macareo LR, Nisalak A, Hermann L, Villa D, Yoon IK. Incidence of Dengue Virus Infection in Adults and Children in a Prospective Longitudinal Cohort in the Philippines. PLoS Negl Trop Dis. 2016 Feb; 10(2):e0004337.
-
Haran JP, Hoaglin DC, Chen H, Boyer EW, Lu S. Antigen-specific H1N1 influenza antibody responses in acute respiratory tract infections and their relation to influenza infection and disease course. J Clin Virol. 2014 Aug; 60(4):367-73.
-
Golekoh MC, Hu S, Norman AM, Horn PS, Brady RC, Wong BL. Comparison of the immunogenicity of intramuscular versus subcutaneous administration of trivalent inactivated influenza vaccine in individuals with neuromuscular diseases. J Child Neurol. 2013 May; 28(5):596-601.
-
Co MD, Cruz J, Takeda A, Ennis FA, Terajima M. Comparison of complement dependent lytic, hemagglutination inhibition and microneutralization antibody responses in influenza vaccinated individuals. Hum Vaccin Immunother. 2012 Sep; 8(9):1218-22.
-
Mathew A, West K, Kalayanarooj S, Gibbons RV, Srikiatkhachorn A, Green S, Libraty D, Jaiswal S, Rothman AL. B-cell responses during primary and secondary dengue virus infections in humans. J Infect Dis. 2011 Nov 15; 204(10):1514-22.
-
Wang S, Parker C, Taaffe J, Sol?rzano A, Garc?a-Sastre A, Lu S. Heterologous HA DNA vaccine prime--inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses. Vaccine. 2008 Jul 04; 26(29-30):3626-33.
-
Abdel-Motal UM, Guay HM, Wigglesworth K, Welsh RM, Galili U. Immunogenicity of influenza virus vaccine is increased by anti-gal-mediated targeting to antigen-presenting cells. J Virol. 2007 Sep; 81(17):9131-41.
-
Kaine JL, Kivitz AJ, Birbara C, Luo AY. Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab. J Rheumatol. 2007 Feb; 34(2):272-9.
-
Alamares JG, Li J, Iorio RM. Monoclonal antibody routinely used to identify avirulent strains of Newcastle disease virus binds to an epitope at the carboxy terminus of the hemagglutinin-neuraminidase protein and recognizes individual mesogenic and velogenic strains. J Clin Microbiol. 2005 Aug; 43(8):4229-33.